相关实验视频

Updated: May 11, 2026

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

在转移性乳腺癌中测序ADC的现状

Shannon McLaughlin¹, Lis V Ravani¹, Beverly Moy¹

¹Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Therapeutic advances in medical oncology

|December 22, 2025

概括

抗体-药物合物 (ADC) 正在改变先进的乳腺癌治疗. 本综述探讨了ADC的最佳测序策略,耐药性机制和未来的疗法,以提高患者的治疗结果.

科学领域:

在瘤学瘤学.
药理学药理学是指药理学的学科.

背景情况:

抗体-药物合物 (ADC) 显著提升了晚期乳腺癌的治疗环境.
ADCs利用向抗体来传递细胞毒性有效载荷,提高有效性并减少全身毒性.

研究的目的:

在乳腺癌治疗中对测序多个ADC的当前知识进行审查.
探索对ADC抵抗机制的翻译性见解.
讨论新兴的ADC和开发中的组合疗法.

主要方法:

对ADC测序的回顾性临床数据的审查.
对ADC耐药性机制的翻译研究的分析.
对管道中的新型ADC和组合剂的调查.

主要成果:

目前关于ADC测序的数据主要是追溯的,强调了前性研究的必要性.
了解抵抗机制对于优化顺序ADC治疗至关重要.
目前正在研究许多新型的ADC和组合策略.

结论:

在晚期乳腺癌中,ADC的最佳测序仍然是一个开放的问题.
对抗药性和新型治疗组合的进一步研究是必不可少的.
晚期乳腺癌治疗的未来可能将涉及复杂的ADC测序和组合方法.

关键词:

抗体 - 药物联合体乳腺癌乳腺癌乳腺癌药物耐药性耐药性药物耐药性转移转移转移转移有针对性的治疗.翻译研究是翻译研究.治疗顺序的顺序处理.

更多相关视频

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.